MELISA WEAVER: Open Payments
NPI 1033240056 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 80 payments from 20 companies in 2025. Trend: 2023 $294 · 2024 $775 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $218 |
| Otsuka America Pharmaceutical, Inc. | 11 | $210 |
| Corcept Therapeutics | 9 | $174 |
| Xeris Pharmaceuticals, Inc. | 6 | $172 |
| ABBVIE INC. | 9 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $86 |
| Almatica Pharma LLC | 3 | $73 |
| SHIELD THERAPEUTICS INC | 3 | $71 |
| Lilly USA, LLC | 4 | $69 |
| Radius Health, Inc. | 4 | $63 |
Products named: REXULTI, Korlym, RECORLEV, Ozempic, Kerendia, TERIPARATIDE, Wegovy, ACCRUFER.
Industry payments across OK — which companies pay providers there.
